Mechanical thrombectomy is a ground breaking treatment for acute ischaemic stroke caused
by occlusion of a large vessel. Its efficacy over intravenous thrombolysis has been proven in …

Rapid, safe and effective arterial recanalisation to restore blood flow and improve functional
outcome remains the primary goal of hyperacute ischaemic stroke management. The benefit …

The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis
within 4.5 hours from stroke onset. An alternative method of restoring blood flow is …

Stroke remains a major worldwide threat to health despite substantial improvements in both
prevention and treatment in recent years. In Western countries, ischaemic stroke due to …

Acute ischemic stroke is the leading cause of severe disability and the third leading cause of
death in the USA. Intravenous tissue plasminogen activator (IV tPA) remains the most widely …

Background Until recently, intravenous thrombolysis was the only reperfusion therapy with
proven efficacy in patients with acute ischemic stroke. However, this treatment option has …

The recent success of endovascular stroke treatment has heralded a new era in the
management of acute ischemic stroke (AIS) with significantly improved outcome for patients …

Background Recent clinical trials have demonstrated the efficacy of mechanical
thrombectomy in acute ischemic stroke. Aims To determine the cost-effectiveness, value of …

The original version of this consensus statement on mechanical thrombectomy was
approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference …

After being staggered by numerous negative trials in 2013, the interventional stroke
community saw four years of vindication for mechanical thrombectomy showing efficacy and …